Available Trials
Latest Clinical Trials
10
Page 1 of 1
| Studies of in-vivo 5-fluorouracil pharmacokinetics, with and without bevacizumab in patients with liver metastases from adenocarcinoma of the colon
Disease/Condition: Colon Cancer Principal Investigator: Howard S Hochster |
| Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma (Fol-BRITe) Disease/Condition: Follicular Lymphoma Principal Investigator: Dennis L. Cooper |
| KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy Disease/Condition: Non Small Cell Lung Cancer Principal Investigator: Daniel Morgensztern |
| A Multi-center pilot study of the effect of Sorafenib on Portal Pressure in Patients with Cirrhosis, Significant Portal Hypertension and Hepatocellular Carcinoma Disease/Condition: Hepatocellular Carcinoma Principal Investigator: Guadalupe Garcia-Tsao |
| A Multicenter, Randomized, Double-Blind Phase 3 Study of Ramucirumab and Best Supportive Care Versus Placebo and BSC as Second-Line Treatment in Patients with Hepatocellular Carcinoma Disease/Condition: Hepatocellular Carcinoma | Liver Cancer Principal Investigator: Stacey M Stein |
| A Phase 1, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of Ascending Doses of AZD4547 in Patients with Advanced Solid Tumor Malignancies Disease/Condition: Advanced Solid Cancers Principal Investigator: Howard S Hochster |
| A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113 Disease/Condition: Advanced Malignancies | Anaplastic Large Cell Lymphoma | Carcinoma, Non-Small-Cell Lung | Diffuse Large Cell Lymphoma | Inflammatory Myofibroblastic Tumors Principal Investigator: Scott Nicholas Gettinger |
| Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma Disease/Condition: Smoldering Myeloma Principal Investigator: Madhav V. Dhodapkar |
| Weekly Paclitaxel with or without AMG 386 for recurrent ovarian cancer Disease/Condition: Recurrent Ovarian Cancer Principal Investigator: Thomas Rutherford |
| Phase III Lenalidomide/Dexamethasone +/- Elotuzumab Previously Untreated Multiple Myeloma Disease/Condition: Multiple Myeloma Principal Investigator: Dhodapkar, Madhav |
| Vorinostat in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma Disease/Condition: Advanced Stage Diffuse Large B-Cell Lymphoma Principal Investigator: Daniel O. Persky |
| Phase I/IIa First Time in Human study of GSK2636771 in subjects with advanced solid tumors Disease/Condition: Breast Cancer (ER, PR, and HER2 negative) | Colorectal Cancer | Endometrial Cancer | Gastric Adenocarcinoma | Glioblastoma Multiforme | Head/ Neck Squamous Cell Carcinoma | Melanoma | Non-Small Cell Lung Cancer (NSCLC) | Ovarian Cancer | Prostate Cancer Principal Investigator: Roy Herbst |
| A study of two new drugs for children with solid tumors that have come back after treatment and are difficult to treat Disease/Condition: Recurrent or Refractory Solid Tumors Principal Investigator: Nina Kadan-Lottick |
| A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using PET Imaging Disease/Condition: Hodgkin Lymphoma Principal Investigator: Stuart Evan Seropian |
| A Phase III trial of Chemotherapy for patients with metastatic head and neck cancer Disease/Condition: Head and Neck Cancer Principal Investigator: Hari Anant Deshpande |
| A Pilot Pre-Operative Window Trial of Black Cohosh in Women with Ductal Carcinoma in situ Disease/Condition: Breast Ductal Carcinoma In Situ (DCIS) Principal Investigator: Erin Wysong Hofstatter |
| A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients Disease/Condition: Anaplastic Large Cell Lymphoma (ALCL) | Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | other transformed T-cell lymphomas Principal Investigator: Francine M Foss |
| A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients using ColoPrint Disease/Condition: Colon Cancer Principal Investigator: Vikram Reddy |
| A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients Disease/Condition: Breast Cancer Principal Investigator: Anees B. Chagpar |
| A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Disease/Condition: Breast Cancer Principal Investigator: Erin Wysong Hofstatter |
| Phase II-III study to Evaluate the Efficacy and Safety of T-DM1 versus. Taxane in HER-2 positive Gastric Cancer and Gastroesophageal Cancer Disease/Condition: Adenocarcinoma of the Gastroesophageal Junction | Gastric Cancer Principal Investigator: Howard S Hochster |
| A Randomized Study Evaluating the Efficacy and Safety of MetMab in Combination of 5FU and mFOLOFOX6 in Patients With Metastatic HER2-Negative Gastroesophageal Cancer Disease/Condition: Gastroesophageal Cancer Principal Investigator: Jill Lacy |
| Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Disease/Condition: Non Small Cell Lung Cancer Principal Investigator: Roy Herbst |
| A Single-arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates Disease/Condition: Hypercalcemia Principal Investigator: Karl L. Insogna |
| ACRIN 6690: A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of Hepatocellular Carcinoma and Liver Transplant Allocation Disease/Condition: Liver Cancer Principal Investigator: Jeffrey C. Weinreb |
| Celldex Glioblastoma ACT IV Study Disease/Condition: Glioblastoma Principal Investigator: Kevin Patrick Becker |
| An Intervention to Improve Outcomes in Patients With Advanced Cancer Disease/Condition: Cancer Principal Investigator: Ruth McCorkle, RN, PhD |
| An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects with Primary Myelofibrosis, Post Essential Thromboythemia Myelofibrosis and Post Polycythemia Vera Myelofibrosis Who Have Platelet Counts of 50x109 /L to 100 x 109/L Disease/Condition: Post Essential Thromboythemia Myelofibrosis | Post Polycythemia Vera Myelofibrosis | Primary Myelofibrosis Principal Investigator: Nikolai Alexandrovich Podoltsev |
| Assessment Tool for Older Patients With Cancer Disease/Condition: Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Unspecified Adult Solid Tumor, Protocol Specific Principal Investigator: Gross, Cary P |
| BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study Disease/Condition: Non Small Cell Lung Cancer Principal Investigator: Roy Herbst |
| Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Disease/Condition: Neuroblastoma Principal Investigator: Kupfer, Gary |
| Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Disease/Condition: Leukemia | Lymphoma Principal Investigator: Gary Kupfer |
| Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Disease/Condition: Cognitive/Functional Effects | Leukemia | Long-term Effects Secondary to Cancer Therapy in Children | Neurotoxicity | Psychosocial Effects of Cancer and Its Treatment Principal Investigator: Gary Kupfer |
| Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Disease/Condition: Endometrial Cancer Principal Investigator: Masoud Azodi |
| Cardiovascular Risk Assessment in Women with Early Breast Cancer Disease/Condition: Breast Cancer Principal Investigator: Jessica Marie Coviello |
| Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Disease/Condition: Fungal Infection | Leukemia | Neutropenia Principal Investigator: Nina Kadan-Lottick |
| Cetuximab and Radiation Therapy in Head and Neck Cancer Disease/Condition: Head and Neck Cancer Principal Investigator: Roy Decker |
| Characterization of Tumor Cells in the Arterial and Venous Circulations of Non Small Cell Lung Cancer Patients Disease/Condition: Non Small Cell Lung Cancer Principal Investigator: Daniel J. Boffa |
| Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Disease/Condition: Untreated Childhood Medulloblastoma | Untreated Childhood Pineoblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Principal Investigator: Gary Kupfer |
| Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Disease/Condition: Fallopian Tube Cancer | Ovarian Cancer | Primary Peritoneal Cavity Cancer Principal Investigator: Thomas J. Rutherford |
| Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Disease/Condition: Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer | Stage IIIA Non-small Cell Lung Cancer Principal Investigator: Scott Nicholas Gettinger |
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Disease/Condition: Chordoma | Desmoid Tumor | Sarcoma Principal Investigator: Gary Kupfer |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Disease/Condition: Rhabdomyosarcoma Principal Investigator: Gary Kupfer |
| Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Disease/Condition: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET) | Childhood Supratentorial Primitive Neuroectodermal Tumor | Ewing Sarcoma of Bone | Extraosseous Ewing Sarcoma | Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Peripheral Primitive Neuroectodermal Tumor of the Kidney | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Principal Investigator: Gary Kupfer |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer Disease/Condition: Childhood Hepatoblastoma | Stage I Childhood Liver Cancer | Stage II Childhood Liver Cancer | Stage III Childhood Liver Cancer | Stage IV Childhood Liver Cancer Principal Investigator: Nina Kadan-Lottick |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Disease/Condition: Contiguous Stage II Adult Lymphoblastic Lymphoma | Noncontiguous Stage II Adult Lymphoblastic Lymphoma | Stage II Adult T-cell Leukemia/Lymphoma | Stage II Childhood Lymphoblastic Lymphoma | Stage III Adult Lymphoblastic Lymphoma | Stage III Adult T-cell Leukemia/Lymphoma | Stage III Childhood Lymphoblastic Lymphoma | Stage IV Adult Lymphoblastic Lymphoma | Stage IV Adult T-cell Leukemia/Lymphoma | Stage IV Childhood Lymphoblastic Lymphoma | T-cell Adult Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia Principal Investigator: Gary Kupfer |
| Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma Disease/Condition: Brain Tumor | Central Nervous System Tumor Principal Investigator: Gary Kupfer |
| Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma Disease/Condition: Multiple Myeloma Principal Investigator: Madhav Dhodapkar, M.D. |
| Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD) Disease/Condition: Hepatic Veno-Occlusive Disease Principal Investigator: Stuart Evan Seropian |
| Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma Disease/Condition: Malignant Melanoma Principal Investigator: Mario Sznol |
| Epidemiology and Genetics of Early Onset Basal Cell Carcinoma Disease/Condition: Basal Cell Carcinoma Principal Investigator: Susan T Mayne |
| Evaluation of Trastuzumab In Patients With HER2 Positive Persistent Or Recurrent Vulvar Paget's Disease Disease/Condition: Paget's Disease of the Vulva Principal Investigator: Thomas J. Rutherford, MD, PhD |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Disease/Condition: Distal Urethral Cancer | Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Proximal Urethral Cancer | Recurrent Bladder Cancer | Recurrent Prostate Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Urethral Cancer | Stage IV Bladder Cancer | Stage IV Prostate Cancer | Transitional Cell Carcinoma of the Bladder | Urethral Cancer Associated With Invasive Bladder Cancer Principal Investigator: Hari A. Deshpande |
| HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer Disease/Condition: Advanced Breast Cancer Principal Investigator: Abu-Khalaf, Maysa Mahmoud |
| Her2, c-kit EGFR and akt1 Expression in Carcinosarcomas of Female Genital Tract: Prognostic Factors or Potential Markers for Targeted Therapies Disease/Condition: Gynecological Cancers Principal Investigator: Ozlen Saglam |
| Hormones and Physical Exercise Study Disease/Condition: Cancer Principal Investigator: Melinda Liggett Irwin |
| Imaging the Effects of Chemotherapy on Cognitive Function in high-grade lymphoma Disease/Condition: Lymphoma Principal Investigator: Herta H Chao |
| Immune Function in T-Cell Lymphoma Disease/Condition: Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral Principal Investigator: Francine M Foss |
| Immunology and Pathobiology of Plasma Cell Disorders Disease/Condition: Plasma cell disorder Principal Investigator: Madhav V. Dhodapkar |
| Impact of Exercise on Ovarian Cancer Prognosis Disease/Condition: Ovarian Cancer Principal Investigator: Melinda Liggett Irwin |
| Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster |
| Neuroblastoma Antibody Study Disease/Condition: Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma Principal Investigator: Nina Kadan-Lottick |
| Longitudinal Assessment and Functional Outcomes in Patients with Hematologic Malignancies and Related Disorders Disease/Condition: Hematologic Malignancies Principal Investigator: Stephanie Halene |
| Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies Disease/Condition: Accelerated Phase Chronic Myelogenous Leukemia | Acute Myeloid Leukemia/Transient Myeloproliferative Disorder | Acute Undifferentiated Leukemia | Angioimmunoblastic T-cell Lymphoma | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Blastic Phase Chronic Myelogenous Leukemia | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission | Childhood Burkitt Lymphoma | Childhood Chronic Myelogenous Leukemia | Childhood Diffuse Large Cell Lymphoma | Childhood Grade III Lymphomatoid Granulomatosis | Childhood Immunoblastic Large Cell Lymphoma | Childhood Myelodysplastic Syndromes | Childhood Nasal Type Extranodal NK/T-cell Lymphoma | Chronic Eosinophilic Leukemia | Chronic Myelomonocytic Leukemia | Chronic Neutrophilic Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Cutaneous B-cell Non-Hodgkin Lymphoma | Essential Thrombocythemia | Extramedullary Plasmacytoma | Intraocular Lymphoma | Isolated Plasmacytoma of Bone | Juvenile Myelomonocytic Leukemia | Long-term Effects Secondary to Cancer Therapy in Children | Mast Cell Leukemia | Meningeal Chronic Myelogenous Leukemia | Monoclonal Gammopathy of Undetermined Significance | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera | Post-transplant Lymphoproliferative Disorder | Primary Central Nervous System Hodgkin Lymphoma | Primary Central Nervous System Non-Hodgkin Lymphoma | Primary Myelofibrosis | Primary Systemic Amyloidosis | Progressive Hairy Cell Leukemia, Initial Treatment | Prolymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Secondary Myelodysplastic Syndromes | Stage 0 Chronic Lymphocytic Leukemia | Stage I Childhood Anaplastic Large Cell Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage I Childhood Large Cell Lymphoma | Stage I Childhood Lymphoblastic Lymphoma | Stage I Childhood Small Noncleaved Cell Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage I Multiple Myeloma | Stage I Mycosis Fungoides/Sezary Syndrome | Stage II Childhood Anaplastic Large Cell Lymphoma | Stage II Childhood Hodgkin Lymphoma | Stage II Childhood Large Cell Lymphoma | Stage II Childhood Lymphoblastic Lymphoma | Stage II Childhood Small Noncleaved Cell Lymphoma | Stage II Chronic Lymphocytic Leukemia | Stage II Cutaneous T-cell Non-Hodgkin Lymphoma | Stage II Multiple Myeloma | Stage II Mycosis Fungoides/Sezary Syndrome | Stage III Childhood Anaplastic Large Cell Lymphoma | Stage III Childhood Hodgkin Lymphoma | Stage III Childhood Large Cell Lymphoma | Stage III Childhood Lymphoblastic Lymphoma | Stage III Childhood Small Noncleaved Cell Lymphoma | Stage III Chronic Lymphocytic Leukemia | Stage III Cutaneous T-cell Non-Hodgkin Lymphoma | Stage III Multiple Myeloma | Stage III Mycosis Fungoides/Sezary Syndrome | Stage IV Childhood Anaplastic Large Cell Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage IV Childhood Large Cell Lymphoma | Stage IV Childhood Lymphoblastic Lymphoma | Stage IV Childhood Small Noncleaved Cell Lymphoma | Stage IV Chronic Lymphocytic Leukemia | Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IV Mycosis Fungoides/Sezary Syndrome | T-cell Large Granular Lymphocyte Leukemia | Unspecified Childhood Solid Tumor, Protocol Specific | Untreated Childhood Acute Lymphoblastic Leukemia | Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | Untreated Hairy Cell Leukemia | Waldenström Macroglobulinemia Principal Investigator: Gary Kupfer |
| Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Disease/Condition: Leukemia Principal Investigator: Kupfer, Gary |
| Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Disease/Condition: Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Newly Diagnosed Childhood Ependymoma Principal Investigator: Gary Kupfer |
| Lenalidomide, Bendamustine and Rituximab Induction Therapy for CLL Disease/Condition: Chronic Lymphocytic Leukemia Principal Investigator: Terri Lynn Parker |
| Mammosite Breast Brachytherapy Optimization in the Treatment of Breast Carcinoma Disease/Condition: Breast Neoplasms Principal Investigator: Weidhaas, Joanne Barnes |
| Neuropsychological and Behavioral Testing in Young Patients With Cancer Disease/Condition: Chemotherapeutic Agent Toxicity | Cognitive/Functional Effects | Neurotoxicity | Psychosocial Effects of Cancer and Its Treatment | Radiation Toxicity | Unspecified Childhood Solid Tumor, Protocol Specific Principal Investigator: Gary Kupfer |
| Ofatumumab vs. Rituximab Salvage Chemoimmunotherapy followed by ASCT in Relapsed or Refractory DLBCL (ORCHARDD Trial/ Phase III) Disease/Condition: Diffuse Large B Cell Lymphoma Principal Investigator: Stuart Evan Seropian |
| Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster |
| Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Disease/Condition: Ovarian Cancer | Sarcoma Principal Investigator: Dan-Arin Silasi |
| PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Disease/Condition: Limited-stage Diffuse Large B-Cell Lymphoma Principal Investigator: Daniel O. Persky |
| Phase II Study of FOLFIRINOX for Advanced Pancreatic Cancer Disease/Condition: Advanced Pancreatic Cancer | Metastatic Pancreatic Cancer | Pancreatic Cancer Principal Investigator: Jill Lacy, MD |
| Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts Disease/Condition: Myelodysplastic Syndromes Principal Investigator: Nikolai Alexandrovich Podoltsev |
| Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors Disease/Condition: Gastrointestinal Tumors | Metastatic Breast Cancer Principal Investigator: Gina G Chung |
| Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Disease/Condition: Breast Cancer Principal Investigator: Weidhaas, Joanne Barnes |
| Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Disease/Condition: Head and Neck Cancer Principal Investigator: Daniel Morgensztern |
| Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Disease/Condition: Adenocarcinoma of the Esophagus | Adenocarcinoma of the Gastroesophageal Junction | Stage IB Esophageal Cancer | Stage IIA Esophageal Cancer | Stage IIB Esophageal Cancer | Stage IIIA Esophageal Cancer | Stage IIIB Esophageal Cancer Principal Investigator: Bryan William Chang |
| Phase III Study of TAS-102 plus Best Supportive Care versus Placebo plus Best Supportive Care in Patients with Colorectal Cancer Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster |
| Randomized, double-blind, Phase II Study of FOLFOX/Bevacizumab with MetMAb versus Placebo as First-Line Treatment for Patients with Metastatic Colorectal Cancer Disease/Condition: Colorectal Cancer Principal Investigator: Howard S Hochster |
| Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia Disease/Condition: Leukemia Principal Investigator: Gary Kupfer |
| Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD Disease/Condition: Graft Versus Host Disease | Leukemia | Myelodysplastic Syndromes Principal Investigator: Warren Shlomchik, MD |
| Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Disease/Condition: Adult Primary Hepatocellular Carcinoma | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer Principal Investigator: Stacey M Stein |
| Study of Blood Samples From Newborns With Down Syndrome Disease/Condition: Down Syndrome | Leukemia Principal Investigator: Nina Kadan-Lottick |
| Study of Kidney Tumors in Young Patients Disease/Condition: Kidney Cancer | Nonneoplastic Condition Principal Investigator: Gary Kupfer |
| Study of Late-Occurring Complications in Childhood Cancer Survivors Disease/Condition: Cancer Survivor | Cardiovascular Complications | Hematopoietic/Lymphoid Cancer | Unspecified Childhood Solid Tumor, Protocol Specific Principal Investigator: Kupfer, Gary |
| Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer Disease/Condition: Breast Cancer Principal Investigator: Erin Wysong Hofstatter |
| Study of a new drug for soft tissue cancer (rhabdomysarcoma) Disease/Condition: Adult Rhabdomyosarcoma | Alveolar Childhood Rhabdomyosarcoma | Embryonal Childhood Rhabdomyosarcoma | Metastatic Childhood Soft Tissue Sarcoma | Previously Untreated Childhood Rhabdomyosarcoma | Stage IV Adult Soft Tissue Sarcoma Principal Investigator: Nina Kadan-Lottick |
| Testing the Feasibility of a Nurse Patient Navigation Intervention in Lung Cancer Disease/Condition: Lung Cancer Principal Investigator: Ruth McCorkle |
| Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms Tumor Disease/Condition: Kidney Cancer Principal Investigator: Kupfer, Gary |
| Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Disease/Condition: Adult Rhabdomyosarcoma | Alveolar Childhood Rhabdomyosarcoma | Mixed Childhood Rhabdomyosarcoma | Pleomorphic Childhood Rhabdomyosarcoma | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Childhood Rhabdomyosarcoma Principal Investigator: Nina Kadan-Lottick |
| Women With Cancer: An Exercise Study to Promote Health Disease/Condition: Bone Loss | Cancer Principal Investigator: M. Tish Knobf, PhD |
| Women's Experience with Triple Negative Breast Cancer Disease/Condition: Breast Cancer Principal Investigator: Yasemin Turkman |
Page 1 of 1
